Recalls / Firms / Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc.

18 FDA drug recalls on record — 2 Class I.

Date	Class	Drug	Status
2025-07-22	Class II	Lorazepam	Ongoing
2024-07-08	Class I	Acetaminophen	Ongoing
2024-03-12	Class II	Infumorph 200	Ongoing
2023-05-11	Class II	Lorazepam	Terminated
2022-12-16	Class II	Ganciclovir	Terminated
2022-07-11	Class II	Ativan	Terminated
2022-07-11	Class II	Lorazepam	Terminated
2022-07-11	Class II	Lorazepam	Terminated
2022-07-11	Class II	Lorazepam	Terminated
2021-08-05	Class III	Bleomycin	Terminated
2020-12-07	Class II	Sodium Chloride	Terminated
2020-11-03	Class II	Sodium Chloride	Terminated
2020-08-14	Class II	Buprenorphine Hydrochloride	Terminated
2020-06-11	Class II	Irinotecan Hydrochloride	Terminated
2020-06-11	Class II	Irinotecan Hydrochloride	Terminated
2020-01-14	Class III	Methylprednisolone Sodium Succinate	Terminated
2019-12-17	Class I	Ketorolac Tromethamine	Terminated
2019-12-17	Class II	Ketorolac Tromethamine	Terminated